These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8914388)

  • 41. [Antimycobacterial activities of a new quinolone, sparfloxacin].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A clinical experience of DNA probe method for identifying Mycobacterium avium and Mycobacterium intracellulare].
    Tsuda M; Oishi N; Saeki A; Ogawa K; Honda K; Sasamoto M; Michihiro H; Miwa T
    Kekkaku; 1995 Jun; 70(6):369-76. PubMed ID: 7630072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimycobacterial drugs.
    Heifets LB
    Semin Respir Infect; 1994 Jun; 9(2):84-103. PubMed ID: 7973175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
    Sato K; Ebe T
    Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
    Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
    Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 May; 68(5):367-70. PubMed ID: 8331881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Yamamoto M; Kuze F; Sakatani M; Saito H; Shimoide H; Soejima R; Hara K
    Kekkaku; 1997 Jan; 72(1):1-7. PubMed ID: 9038009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
    Sato K; Ogasawara K; Akaki T; Tomioka H
    Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis].
    Kuwabara K; Watanabe Y; Wada K; Tsuchiya T
    Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
    Jenkins PA; Campbell IA; Banks J; Gelder CM; Prescott RJ; Smith AP
    Thorax; 2008 Jul; 63(7):627-34. PubMed ID: 18250184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
    Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
    Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin].
    Baba H
    Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinicopathological study of cases with Mycobacterium szulgai infection].
    Iwanaga T; Kishikawa R; Ikeda T; Hirose T; Tsurutani H; Yoshida S
    Kekkaku; 1998 Oct; 73(10):579-84. PubMed ID: 9844345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience.
    Maliwan N; Zvetina JR
    Postgrad Med J; 2005 Aug; 81(958):530-3. PubMed ID: 16085747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
    Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
    PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Improvement of routine works and quality control in mycobacterial laboratory].
    Suzuki K; Higuchi T
    Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of pulmonary Mycobacterium fortuitum infection successfully treated with Kampo treatments].
    Nogami T; Sekiya N; Mitsuma T; Yamaguchi T
    Kekkaku; 2006 Aug; 81(8):525-9. PubMed ID: 16972656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A clinical study of non-tuberculous pulmonary mycobacteriosis].
    Kurasawa T; Ikeda N; Sato A; Nakatani K; Matsusita Y; Inoue T; Sakatani M; Kobayashi C; Sunda N; Kanai K
    Kekkaku; 1995 Nov; 70(11):621-8. PubMed ID: 8656586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.